Dr Paul McKay looks down a microscope

Imperial staff, students and alumni are working round-the-clock to combat COVID-19. 

Research/Society/Response fund columns

Professor Robin Shattock and a colleague working in the lab with face visors on


Imperial has nearly two thousand key workers helping keep our essential services running and supporting essential COVID-19 research.

Imperial epidemiologists are informing policymakers worldwide. Our virologists are trialing their COVID-19 vaccine. Respiratory specialists are helping understand the progression of the virus and why it hits some patients harder.  Biomedical engineers have developed rapid result coronavirus tests. Data scientists, AI researchers and health economists are among the many Imperial researchers redeploying their expertise to fight the pandemic. And a multidisciplinary team has also set out key regulations innovators must comply with when designing and building technologies safely to tackle COVID-19.

Imperial students delivering food to NHS staff


More than one thousand members of staff and hundreds of students are volunteering to support the NHS. We have converted labs for NHS COVID-19 testing, including one able to handle 1,500 samples per day. Two hundred and eighty final year medical students are joining the NHS frontline months early. We have handed over scores of PCR machines for NHS emergency use. Our students are providing hundreds of free meals to NHS workers

We are sharing our expertise in science, technology, engineering and medicine education, including in COVID-19, with teachers and school pupils via a series of free online materials ideal for those home-schooling during the crisis, and via the world’s most popular free online Coursera course, taught by our academics

Artist's impression of the COVID-19 virus

Response fund

The Imperial College COVID-19 Response Fund supplements government and existing philanthropy to provide flexible support for vital projects in our unprecedented efforts to tackle COVID-19, such as developing vaccines, improving diagnostics, advancing therapies, strengthening epidemiology and providing essential healthcare in the urgent race to defeat the novel coronavirus. A groundswell of support from alumni and friends means the fund is already backing researchers.